About Modi-Mundipharma Private Limited
Data last updated:
Modi-Mundipharma Private Limited is a private limited company based in New, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 31 October 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1990PTC041928. Its GSTIN is 07AAACM2303F1Z4 (Delhi). The company holds 22 GST registrations, of which 20 are active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹30 Lakh. It was formerly known as Modi-Mundipharma Limited. It is led by directors including Abhishek Modi and Kumkum Modi.
Its last annual general meeting (AGM) was held on 31 December 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1400 Modi Tower 98 Nehru Place, New, Delhi, India – 110019.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,314.82 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹36.73 Cr (net margin 2.8%) and EBITDA of ₹133.17 Cr (EBITDA margin 10.1%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 7% over five years.
Its group structure includes 3 subsidiaries.
As per MCA filings, the company has open charges of ₹251.75 Cr and satisfied charges of ₹198.98 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website umeshmodigroup.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address1400 Modi Tower 98 Nehru Place, New, Delhi, India – 110019
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Modi-Mundipharma Private Limited
The main business activities of Modi-Mundipharma are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Modi-Mundipharma Private Limited
Modi-Mundipharma Private Limited is audited by SARAT JAIN & ASSOCIATES. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SARAT JAIN & ASSOCIATES. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Modi-Mundipharma Private Limited
Modi-Mundipharma has 7 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abhishek Modi Also directs: Sbec Sugar Limited, Bihar Sponge Iron Limited, Modi Illva India Private Limited and 5 more | Director | 15 Feb 1995 | 31 Years 7 Months | Current |
| Kumkum Modi | Director | 28 Apr 1993 | 33 Years 5 Months | Current |
| Umesh Kumar Modi | Director | 31 Oct 1990 | 35 Years 11 Months | Current |
| Meghna Modi | Director | 25 Mar 1991 | 35 Years 6 Months | Current |
| Jayesh Modi | Director | 13 Sep 2012 | 14 Years 0 Months | Current |
| Bryan George Lea | Director | 04 Jun 2018 | 8 Years 4 Months | Current |
Financials of Modi-Mundipharma Private Limited FY 2024 filings available
Modi-Mundipharma Private Limited reported revenue of ₹1,314.82 Cr (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Modi-Mundipharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 7% growth in the latest year. EBITDA rose 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Modi-Mundipharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹133.17 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹36.73 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Modi-Mundipharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Modi-Mundipharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Modi-Mundipharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Group Structure of Modi-Mundipharma Private Limited
Modi-Mundipharma has 3 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Modi-Mundipharma Healthcare Private Limited | U24100DL2009PTC188842 | Locked |
| Win-Medicare Private Limited | U51397DL1981PTC011647 | Locked |
| Modi-Mundipharma Beauty Products Private Limited | U74899DL1994PTC057763 | Locked |
Showing major subsidiaries. Total: 3.
Charges & Borrowings of Modi-Mundipharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Feb 2021 | Hdfc Bank Limited | ₹10 Cr | Open |
| 12 Jul 2017 | Hdfc Bank Limited | ₹2.1 Cr | Open |
| 12 Jul 2017 | Hdfc Bank Limited | ₹16.64 Cr | Open |
| 10 Feb 2014 | Others | ₹223.01 Cr | Open |
| 14 Apr 2022 | Others | ₹5 Cr | Satisfied |
Total charge records: 10 View all charges
Employees and EPFO Compliance at Modi-Mundipharma Private Limited
Employment history and EPFO contributions of people linked to Modi-Mundipharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Modi-Mundipharma Private Limited
Modi-Mundipharma has 22 GST registrations: 20 active and 2 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACM2303F1Z4 | Delhi | Active | 01 Jul 2017 |
| 07AAACM2303F2Z3 | Delhi | Active | 24 Aug 2017 |
| 03AAACM2303F1ZC | Punjab | Active | 01 Jul 2017 |
| 05AAACM2303F1Z8 | Uttarakhand | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Modi-Mundipharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Modi-Mundipharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Modi-Mundipharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Modi-Mundipharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Modi-Mundipharma Private Limited
Frequently Asked Questions about Modi-Mundipharma Private Limited
Modi-Mundipharma is an active private limited company based in New, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 31 October 1990 (36+ years old) and is registered under CIN U74899DL1990PTC041928.
Modi-Mundipharma reported revenue of ₹1,314.82 Cr for FY 2025 (up 7% YoY).
Modi-Mundipharma has 7 current directors:
- Abhishek Modi - Director
- Kumkum Modi - Director
- Umesh Kumar Modi - Director
- Meghna Modi - Director
- Jayesh Modi - Director
- Bryan George Lea - Director
- Vijay Kumar Modi - Additional Director
Modi-Mundipharma reported a net profit of ₹36.73 Cr (net margin 2.8%) and EBITDA of ₹133.17 Cr (EBITDA margin 10.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Modi-Mundipharma is 6% over three years and 7% over five years. In the latest year (FY 2025) revenue rose 7%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Modi-Mundipharma is 07AAACM2303F1Z4, registered in Delhi. The company has 22 GST registrations in all, of which 20 are active and 2 are cancelled or inactive. Other active GSTINs include 07AAACM2303F2Z3 (Delhi), 03AAACM2303F1ZC (Punjab), 05AAACM2303F1Z8 (Uttarakhand).
The CIN (Corporate Identification Number) of Modi-Mundipharma is U74899DL1990PTC041928. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Modi-Mundipharma was incorporated on 31 October 1990, making it 36+ years old. It is registered with the Registrar of Companies, Delhi.
Modi-Mundipharma can be reached through the website umeshmodigroup.com. Its registered office is in New, Delhi, India.